Cerity Partners’s Zomedica Corp. ZOM Stock Holding History

Cerity Partners’s Portfolio ZOM Stock Details ZOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-20,000	Closed	-$1.16K	–	2792
2025 Q1	$1.16K	Hold	20,000	–	–	﹤0.01%	2473
2024 Q4	$2.4K	Hold	20,000	–	–	﹤0.01%	2414
2024 Q3	$2.74K	Sell	20,000 -2,300	-10%	-$323	﹤0.01%	2525
2024 Q2	$3.26K	Hold	22,300	–	–	﹤0.01%	2219
2024 Q1	$3.25K	Hold	22,300	–	–	﹤0.01%	2281
2023 Q4	$4.46K	Buy	+22,300	New	+$3.92K	﹤0.01%	1848
2023 Q3	–	Sell	-100,000	Closed	-$20K	–	1767
2023 Q2	$20K	Hold	100,000	–	–	﹤0.01%	1601
2023 Q1	$21.2K	Hold	100,000	–	–	﹤0.01%	1822
2022 Q4	$16.3K	Buy	100,000 +80,000	+400%	+$16.4K	﹤0.01%	1458
2022 Q3	$4K	Hold	20,000	–	–	﹤0.01%	1175
2022 Q2	$4K	Hold	20,000	–	–	﹤0.01%	1179
2022 Q1	$7K	Hold	20,000	–	–	﹤0.01%	935
2021 Q4	$6K	Hold	20,000	–	–	﹤0.01%	1016
2021 Q3	$10K	Hold	20,000	–	–	﹤0.01%	682
2021 Q2	$17K	Buy	+20,000	New	+$18.6K	﹤0.01%	708

Other funds holding ZOM

Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

ASN

Advisory Services Network Atlanta, Georgia $8.83B AUM 38.5% 1-Year Est. Return

SWM

Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return

CSP

Cary Street Partners Richmond, Virginia $4.58B AUM 24% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

FFA

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return

BWL

Bogart Wealth LLC Mclean, Virginia $2.92B AUM 23.85% 1-Year Est. Return

Rossby Financial Melbourne, Florida $547M AUM 30.65% 1-Year Est. Return

Cerity Partners's ZOM Position: Q2 2025 in Review

Cerity Partners sold out of Zomedica Corp. (ZOM) in Q2 2025, closing a stake of 20,000 shares — an estimated $1.16K sold.

Cerity Partners first reported a position in ZOM in Q2 2021 and held it in 15 quarters. The position peaked at $21.2K in Q1 2023. 10 funds tracked by Wall St. Rank hold ZOM as of Q2 2025.

Cerity Partners reported no remaining Zomedica Corp. position as of Q2 2025 after selling out during the quarter.
Cerity Partners sold 20,000 Zomedica Corp. shares in Q2 2025, an estimated $1.16K.
Cerity Partners first reported a position in Zomedica Corp. in Q2 2021 and held it in 15 quarters.
Cerity Partners's Zomedica Corp. position peaked at $21.2K in Q1 2023.
10 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2025.

Based on Cerity Partners's 13F filing for Q2 2025, filed 13 Aug 2025.